You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Low Testosterone Medscape CME Expert Column Series. Issue 4: Monitoring Safety and Efficacy of Testosterone Replacement Therapy

  • Authors: Martin M. Miner, MD
  • CME Released: 1/5/2012
  • Valid for credit through: 1/5/2013, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity was developed for primary care physicians, nurse practitioners (NPs), and physician assistants (PAs).

Clinician concerns about the safety and efficacy of testosterone replacement therapy (TRT) have been implicated as a major reason for undertreatment of hypogonadal men. The solution lies in monitoring patients on TRT to ensure safety while achieving benefits. In both the near term and throughout the patient's course of care, which may be lifelong, a sustained monitoring program offers the best path to successful outcomes. More than just an option, monitoring TRT should be considered an indispensable corollary to the decision to treat. It requires commitment and collaboration by all parties—primary care practitioner, patient, other office health personnel, and specialists who may be consulted—and an understanding of how to proceed over time.

Published guidelines, including those from The Endocrine Society, American Society for Reproductive Medicine, European Association of Urology, International Society of Andrology, and others, are based on evolving principles for TRT monitoring. These principles are thorough and cautious and allow for tailoring to meet the indications and needs of the individual patient.

Upon completion of this activity, participants should be able to:

  1. Discuss the principles and goals of monitoring testosterone replacement therapy (TRT).
  2. Explain the timing and purpose of individual tests and evaluations recommended for TRT monitoring.
  3. Describe recommended actions in response to findings of TRT monitoring.
  4. Recognize the necessity for collaboration of practitioners and patient in TRT monitoring.


No off-label uses of any agent are discussed.

All activity faculty and planners participating in continuing medical education activities sponsored by New York Medical College are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.


  • Martin M. Miner, MD

    Co-director, Men's Health Center, Chief of Family and Community Medicine, The Miriam Hospital, Clinical Associate Professor of Family Medicine and Urology, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island.


    Disclosure: consultant: Auxilium Pharmaceuticals Inc, Eli Lilly and Company, Endo Pharmaceuticals; researcher: Auxilium Pharmaceuticals Inc.

The Planning Committee for this activity included Kathy Kavanagh, Director, and Margaret Astrologo, Assistant Director of New York Medical College; and Ruth Cohen, CCMEP, Vice President, CME Director, and Margaret Inman, Senior Editor of Continuing Education Alliance. The members of the Planning Committee have no significant relationships to disclose.

Accreditation Statements

    For Physicians

  • This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council For Continuing Medical Education (ACCME) through the joint sponsorship of New York Medical College (NYMC) and Continuing Education Alliance. NYMC is accredited by the ACCME to provide continuing medical education for physicians.

    New York Medical College designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.


Low Testosterone Medscape CME Expert Column Series. Issue 4: Monitoring Safety and Efficacy of Testosterone Replacement Therapy

Authors: Martin M. Miner, MDFaculty and Disclosures

CME Released: 1/5/2012

Valid for credit through: 1/5/2013, 11:59 PM EST


This content is no longer available.

  • Print